ITULAZAX lyophilisat oral 12 SQ-Bet 30 pce
7680672750019
CH-67275
V01AA05
07.13.3.
Reimbursement limitations:
071330
Prise en charge seulement après exploration allergologique.
1 / 3
google
Details
- Product number
- 6727501
- CPT
- -
- Packaging group
- 30
- Unit
- Einzeldose(n)
- Composition
- Praeparatio cryodesiccata: pollinis allergeni extractum (Betula pendula) 12 U., gelatina, mannitolum, natrii hydroxidum, pro dosi corresp. natrium 0.49 mg.
Articles (1)
Itulazax, Lyophilisat zum Einnehmen
Lyophilisat
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
12.0 U | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
0.49 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 133.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/08/2020
Authorization holder
ALK-Abelló AG
8304 Wallisellen
Authorization information
- Swissmedic authorization number
- 67275
- Drug name
- Itulazax, Lyophilisat zur sublingualen Anwendung
- Galenic form
- LYSUV
- ATC Code
- V01AA05
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 19/05/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.13.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ITULAZAX lyophilisat oral 12 SQ-Bet 30 pce
- Description (DE)
- ITULAZAX Lyophilisat oral 12 SQ-Bet 30 Stk
- Market launch
- 19/05/2020
- Narcotic (BTM)
- No